Publication | Closed Access

Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial

AngiogenesisLow LevelVascular SarcomasMedicineVascular SurgeryPathologyVascular BiologyNeovascularizationOncologyRadiation OncologyAncillary Study